JP2003277288A5 - - Google Patents
Download PDFInfo
- Publication number
- JP2003277288A5 JP2003277288A5 JP2002376903A JP2002376903A JP2003277288A5 JP 2003277288 A5 JP2003277288 A5 JP 2003277288A5 JP 2002376903 A JP2002376903 A JP 2002376903A JP 2002376903 A JP2002376903 A JP 2002376903A JP 2003277288 A5 JP2003277288 A5 JP 2003277288A5
- Authority
- JP
- Japan
- Prior art keywords
- amino acid
- acid sequence
- same
- cancer
- salt
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Pending
Links
- 125000003275 alpha amino acid group Chemical group 0.000 description 28
- 150000003839 salts Chemical class 0.000 description 15
- 206010028980 Neoplasm Diseases 0.000 description 14
- 201000011510 cancer Diseases 0.000 description 14
- 108090000765 processed proteins & peptides Proteins 0.000 description 14
- 108090000623 proteins and genes Proteins 0.000 description 14
- 102000004169 proteins and genes Human genes 0.000 description 14
- 239000003814 drug Substances 0.000 description 8
- 229940124597 therapeutic agent Drugs 0.000 description 8
- 239000003795 chemical substances by application Substances 0.000 description 7
- 230000000069 prophylactic effect Effects 0.000 description 7
- 150000001875 compounds Chemical class 0.000 description 6
- 238000012216 screening Methods 0.000 description 6
- 230000006907 apoptotic process Effects 0.000 description 4
- 230000001939 inductive effect Effects 0.000 description 4
- 238000000034 method Methods 0.000 description 4
- 239000000032 diagnostic agent Substances 0.000 description 3
- 229940039227 diagnostic agent Drugs 0.000 description 3
- 230000000694 effects Effects 0.000 description 3
- 230000014509 gene expression Effects 0.000 description 3
- 208000003174 Brain Neoplasms Diseases 0.000 description 2
- 102000011787 Histone Methyltransferases Human genes 0.000 description 2
- 108010036115 Histone Methyltransferases Proteins 0.000 description 2
- 206010061902 Pancreatic neoplasm Diseases 0.000 description 2
- 208000024313 Testicular Neoplasms Diseases 0.000 description 2
- 206010057644 Testis cancer Diseases 0.000 description 2
- 208000024770 Thyroid neoplasm Diseases 0.000 description 2
- 230000000692 anti-sense effect Effects 0.000 description 2
- 210000000481 breast Anatomy 0.000 description 2
- 230000000295 complement effect Effects 0.000 description 2
- 210000003238 esophagus Anatomy 0.000 description 2
- 208000024200 hematopoietic and lymphoid system neoplasm Diseases 0.000 description 2
- 230000002401 inhibitory effect Effects 0.000 description 2
- 210000003734 kidney Anatomy 0.000 description 2
- 210000004185 liver Anatomy 0.000 description 2
- 210000004072 lung Anatomy 0.000 description 2
- 208000015486 malignant pancreatic neoplasm Diseases 0.000 description 2
- 239000002773 nucleotide Substances 0.000 description 2
- 125000003729 nucleotide group Chemical group 0.000 description 2
- 210000001672 ovary Anatomy 0.000 description 2
- 201000002528 pancreatic cancer Diseases 0.000 description 2
- 208000008443 pancreatic carcinoma Diseases 0.000 description 2
- 230000002265 prevention Effects 0.000 description 2
- 210000002307 prostate Anatomy 0.000 description 2
- 230000001105 regulatory effect Effects 0.000 description 2
- 210000000952 spleen Anatomy 0.000 description 2
- 210000002784 stomach Anatomy 0.000 description 2
- 201000003120 testicular cancer Diseases 0.000 description 2
- 201000002510 thyroid cancer Diseases 0.000 description 2
- 210000003932 urinary bladder Anatomy 0.000 description 2
- 210000004291 uterus Anatomy 0.000 description 2
Priority Applications (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2002376903A JP2003277288A (ja) | 2001-12-27 | 2002-12-26 | がんの予防・治療剤 |
Applications Claiming Priority (3)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| JP2001398220 | 2001-12-27 | ||
| JP2001-398220 | 2001-12-27 | ||
| JP2002376903A JP2003277288A (ja) | 2001-12-27 | 2002-12-26 | がんの予防・治療剤 |
Publications (2)
| Publication Number | Publication Date |
|---|---|
| JP2003277288A JP2003277288A (ja) | 2003-10-02 |
| JP2003277288A5 true JP2003277288A5 (enExample) | 2006-02-02 |
Family
ID=29252844
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2002376903A Pending JP2003277288A (ja) | 2001-12-27 | 2002-12-26 | がんの予防・治療剤 |
Country Status (1)
| Country | Link |
|---|---|
| JP (1) | JP2003277288A (enExample) |
Families Citing this family (1)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| WO2012164936A1 (en) * | 2011-06-03 | 2012-12-06 | Oncotherapy Science, Inc. | Suv39h2 as a target gene for cancer therapy and diagnosis |
-
2002
- 2002-12-26 JP JP2002376903A patent/JP2003277288A/ja active Pending
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EP1999149A4 (en) | ANTI-IGF-1R ANTIBODIES AND USES THEREOF | |
| MX364100B (es) | Péptidos protectores de tejido y sus usos. | |
| WO2003016475A3 (en) | Nucleic acid and amino acid sequences involved in pain | |
| WO2004006838A3 (en) | Novel kinases | |
| WO2003089456A3 (en) | Peptide inhibitors of protein kinase c | |
| WO2006108718B1 (en) | Micro rna | |
| WO2003013534A3 (en) | Methods for the treatment of cancer with irinotecan based on cyp3a5 | |
| WO2001055178A3 (en) | Liv-1 related protein, polynucleotides encoding the same and use thereof for treatment of cancer | |
| BR0306715A (pt) | Métodos para diagnóstico e tratamento de tumores | |
| WO2002061076A1 (fr) | Proteine associee a l'adiponectine | |
| MXPA02008239A (es) | Gen humano de la esquizofrenia. | |
| ATE536745T1 (de) | Zusammensetzung mit arazym zur prävention und behandlung von krebs | |
| WO2001004157A3 (en) | NOVEL METHOD AND COMPOSITION FOR INHIBITION OF ANGIOGENESIS USING ANTAGONISTS BASED ON MMP-9 AND β1 INTEGRINS | |
| IL149416A0 (en) | Human enzymes of the metalloprotease family | |
| JP2006158399A5 (ja) | 細胞増殖抑制タンパク質並びにそれを用いる細胞増殖抑制剤、癌診断薬及び癌治療剤 | |
| JP2003277288A5 (enExample) | ||
| JP2003277289A5 (enExample) | ||
| DE69924877D1 (en) | Humanes akt-3 protein | |
| EP1282641A4 (en) | Cervical cancer suppressing protein in women, polynucleotide encoding it, cell transformed by polynucleotide, and method of suppressing proliferation of cancer cells using the expression vector | |
| EP1677739A4 (en) | METHODS FOR IDENTIFYING AGENTS THAT INHIBIT THE GROWTH OF CANCER CELLS | |
| TW200517125A (en) | Pharmaceutical composition for treatment of solid cancers | |
| ATE405827T1 (de) | Screening-verfahren | |
| WO2002070559A3 (en) | Nuclear hormone receptor ligand binding domains | |
| ATE304593T1 (de) | Menschliches gen und protein eines magenkrebs- antigens | |
| JP2002355060A5 (enExample) |